"Troponin I" - Books

Result Filters

See Gene information for troponin troponin i

troponin in Schistocerca gregaria Symsagittifera roscoffensis Sparus aurata All 3 Gene records

troponin i in Clupea harengus (3)All 3 Gene records

Results: 1 to 20 of 116 books (670 items)

<< First< Prev

Page of 6

Next >Last >>

Select item 42634001.

Point-of-Care Troponin Testing in Patients With Symptoms Suggestive of Acute Coronary Syndrome: A Health Technology Assessment [Internet].

Ho C, Cimon K, Weeks L, et al.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Mar. (CADTH Optimal Use Report, No. 5.1b.)

Top results in this book Table of Contents

Select item 32975682.

Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease [Internet].

Michos ED, Berger Z, Yeh HC, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Aug. (Comparative Effectiveness Review, No. 135.)

Top results in this book Table of Contents

Select item 44036683.

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2024 Jan-.

Top results in this book Table of Contents

Select item 30580364.

High-Sensitivity Cardiac Troponin for the Rapid Diagnosis of Acute Coronary Syndrome in the Emergency Department: A Clinical and Cost-Effectiveness Evaluation [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2013 Mar. (CADTH Optimal Use Report, No. 2.1A.)

Top results in this book Table of Contents

Select item 52049225.

High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation.

Westwood M, Ramaekers B, Grimm S, et al.

Southampton (UK): NIHR Journals Library; 2021 May. (Health Technology Assessment, No. 25.33.)

Top results in this book Table of Contents

Select item 33382086.

Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome.

Goodacre S, Thokala P, Carroll C, et al.

Southampton (UK): NIHR Journals Library; 2013 Jan. (Health Technology Assessment, No. 17.1.)

Top results in this book Table of Contents

Select item 26591827.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].

York (UK): Centre for Reviews and Dissemination (UK); 1995-.

Top results in this book Table of Contents

Select item 54813408.

Accelerated Diagnostic Protocols Using High-sensitivity Troponin Assays to “Rule In” or “Rule Out” Myocardial Infarction in the Emergency Department: A Systematic Review.

Jutkowitz E, Hsiao J, Celedon M, et al.

Washington (DC): Department of Veterans Affairs (US); 2023 Mar.

Top results in this book Table of Contents

Select item 42630489.

Point-of-Care Troponin Testing in Patients With Symptoms Suggestive of Acute Coronary Syndrome: Recommendations [Internet].

Ho C, Cimon K, Weeks L, et al.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Mar. (CADTH Optimal Use Report, No. 5.1c.)

Top results in this book Table of Contents

Select item 487798610.

Clinical Review Report: Patisiran (Onpattro): (Alnylam Netherlands B.V.): Indication: Treatment of polyneuropathy in adult patients with hereditary transthyretin-mediated amyloidosis [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Aug.

Top results in this book Table of Contents

Select item 549568211.

Caplacizumab (Cablivi): CADTH Reimbursement Review: Therapeutic area: Acquired thrombotic thrombocytopenic purpura [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Jul.

Top results in this book Table of Contents

Select item 437650012.

Using nationwide ‘big data’ from linked electronic health records to help improve outcomes in cardiovascular diseases: 33 studies using methods from epidemiology, informatics, economics and social science in the ClinicAl disease research using LInked Bespoke studies and Electronic health Records (CALIBER) programme.

Hemingway H, Feder GS, Fitzpatrick NK, et al.

Southampton (UK): NIHR Journals Library; 2017 Jan. (Programme Grants for Applied Research, No. 5.4.)

Top results in this book Table of Contents

Select item 550103413.

Mavacamten (Camzyos): CADTH Reimbursement Review: Therapeutic area: Obstructive hypertrophic cardiomyopathy [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Jun.

Top results in this book Table of Contents

Select item 562153814.

Monitoring Patients With Psychotic Disorders for Clozapine-Induced Myocarditis or Cardiomyopathy: Rapid Review [Internet].

Lachance CC, Mierzwinski-Urban M; Authors.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Top results in this book Table of Contents

Select item 408120215.

High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis.

Westwood M, van Asselt T, Ramaekers B, et al.

Southampton (UK): NIHR Journals Library; 2015 Jun. (Health Technology Assessment, No. 19.44.)

Top results in this book Table of Contents

Select item 514852216.

Clinical Review Report: Caplacizumab (Cablivi): (Sanofi Genzyme, a division of Sanofi-Aventis Canada Inc.): Indication: Indicated for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP) in combination with plasma exchange (PEX) and immunosuppressive therapy [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Oct.

Top results in this book Table of Contents

Select item 334569617.

Randomised Assessment of Treatment using Panel Assay of Cardiac markers – Contemporary Biomarker Evaluation (RATPAC CBE).

Collinson PO, Gaze DC, Thokala P, et al.

Southampton (UK): NIHR Journals Library; 2013 Apr. (Health Technology Assessment, No. 17.15.)

Top results in this book Table of Contents

Select item 428437218.

Effect of Remote Ischaemic preconditioning on Clinical outcomes in patients undergoing Coronary Artery bypass graft surgery (ERICCA study): a multicentre double-blind randomised controlled clinical trial.

Hausenloy DJ, Candilio L, Evans R, et al.

Southampton (UK): NIHR Journals Library; 2016 Jun. (Efficacy and Mechanism Evaluation, No. 3.4.)

Top results in this book Table of Contents

Select item 445172219.

Diagnostic and therapeutic medical devices for safer blood management in cardiac surgery: systematic reviews, observational studies and randomised controlled trials.

Murphy GJ, Mumford AD, Rogers CA, et al.

Southampton (UK): NIHR Journals Library; 2017 Sep. (Programme Grants for Applied Research, No. 5.17.)

Top results in this book Table of Contents

Select item 466763420.

Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update [Internet].

Sanders GD, Lowenstern A, Borre E, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Oct. (Comparative Effectiveness Reviews, No. 214.)

Top results in this book Table of Contents

<< First< Prev

Page of 6

Next >Last >>

Supplemental Content

Images search in Bookshelf

Figure 5Sensitivity and specificity of elevated troponin I in the diagnosis of acute coronary syndrome among patients with chronic kidney disease

Closed markers represent studies that adjudicated acute coronary syndrome, open markers represent studies that either did not adjudicate or did not report adjudicating acute coronary syndrome. Diamond markers indicate a troponin I cutoff of less than 0.1 mcg/L. Round markers indicate a troponin I cutoff between 0.1 mcg/L and 0.5 mcg/L. Square markers indicate a troponin I cutoff between 0.5 and 1.0 mcg/L. Triangular markers indicate a troponin I cutoff greater than or equal to 1.0 mcg/L.
* Indicates a dialysis population.
† Indicates a non-dialysis population.
‡ Indicates a mixed population
§ Does not specify if the population is on dialysis or not.

Results.

Michos ED, Berger Z, Yeh HC, et al. Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Aug.
Figure BSensitivity and specificity of troponin I elevation in the diagnosis of acute coronary syndrome (ACS) versus non-ACS among patients with chronic kidney disease

Closed markers represent studies that adjudicated acute coronary syndrome, open markers represent studies that either did not adjudicate or did not report adjudicating acute coronary syndrome. Diamond markers indicate a troponin I cutoff of less than 0.1 mcg/L. Round markers indicate a troponin I cutoff between 0.1 mcg/L and 0.5 mcg/L. Square markers indicate a troponin I cutoff between 0.5 and 1.0 mcg/L. Triangular markers indicate a troponin I cutoff greater than or equal to 1.0 mcg/L.
* Indicates a dialysis population.
† Indicates a non-dialysis population.
‡ Indicates a mixed population
§ Does not specify if the population is on dialysis or not.

Executive Summary.

Michos ED, Berger Z, Yeh HC, et al. Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Aug.
Figure 3. Risk of death: Troponin I

Results.

Heidenreich PA, Go A, Melsop KA, et al. Prediction of Risk for Patients with Unstable Angina. Rockville (MD): Agency for Healthcare Research and Quality (US); 2000 Dec.
Figure 10Pooled unadjusted odds ratio of the association of an elevated troponin I with all-cause mortality among patients on dialysis (sorted by prevalence)

* Study used a troponin assay manufactured by Diagnostic Products Corporation.
† Study used a troponin assay manufactured by Dade.
‡ Study used a troponin assay manufactured by Beckman.
§ Study used a troponin assay manufactured by Abbott.
ǁ Study used a troponin assay manufactured by Siemens.
¶ Study used a troponin assay manufactured by Sanofi.
** Study used a troponin assay manufactured by Ortho.
CI = confidence interval; cTnI = cardiac troponin I; elev = elevated; mcg/L = micrograms per liter; NR = not reported; OR = odds ratio; yrs = years
Boxes indicate individual study point estimates. The box size denotes the weight of the study, with larger boxes contributing more to the pooled estimate. The width of the horizontal lines represents the 95 percent confidence intervals for each study.

Results.

Michos ED, Berger Z, Yeh HC, et al. Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Aug.